Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Recent advances in diagnosis and treatment are dramatically changing the management landscape for many non-melanoma skin cancers (NMSCs). Despite the impressive pace of change in some areas such as immunotherapy for treatment of advanced disease, there remain many critical unanswered clinical and scientific questions which have a direct impact on patient outcomes. In this chapter we consider aspects of these key areas and ongoing and potential future research initiatives designed to address them. With a particular focus on keratinocyte cancers, we consider prospects for improved epidemiological approaches to understanding the future burden of disease, advances in clinicopathological diagnosis and risk prediction, knowledge gaps in current medical and surgical treatments and advances in radiotherapy, including international data-sharing projects and brachytherapy. Although this is inevitably a highly selective synopsis, we aim to provide a glimpse of future directions which are likely to have a significant impact in the near future on optimising NMSC management and improving patient outcomes for these common human cancers.

Original publication

DOI

10.1201/9781003226017-30

Type

Chapter

Book title

Non-melanoma Skin Cancer: Essentials for Oncologists

Publication Date

01/01/2023

Pages

407 - 426